vimarsana.com
Home
Live Updates
Nuformix loss narrows; near-term goal to focus on NXP002 ass
Nuformix loss narrows; near-term goal to focus on NXP002 ass
Nuformix loss narrows; near-term goal to focus on NXP002 asset
Nuformix PLC on Monday reported a narrowed annual loss as it made progress on optimising costs and furthering its lead asset, NXP002.
Nuformix is a London-based pharmaceutical development company... | May 22, 2023
Related Keywords
London ,
City Of ,
United Kingdom ,
Dan Gooding ,
Heather Rydings ,
Alliance News Ltd ,
Alliance News ,
Director Dan Gooding ,
All Rights ,
Nuformix Plc Stock Exchange ,
News ,
Information ,
Press Release ,
Nuformix ,
Lc ,
N ,
Monday ,
Eported ,
Narrowed ,
Nnual ,
Boss ,
Us ,
It ,
Rade ,
Progress ,
Optimising ,
Costs ,
End ,
Furthering ,
Its ,
Head ,
Harmaceutical ,
Evelopment Lvrt Gb00byw79y38 ,